Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05917860 |
Title | Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer (NeoADT-TULSA) |
Acronym | NeoADT-TULSA |
Recruitment | Recruiting |
Gender | male |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Turku University Hospital |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FIN |